SIDEROS, the largest ongoing trial in Duchenne
Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD) Pratteln, Switzerland, May 20, 2020 Original press release Santhera [...]
Press release from Pfizer about gene therapy
Pfizer’s new phase 1b results of gene therapy in ambulatory boys with Duchenne muscular dystrophy (DMD) support advancement into pivotal phase 3 study Read the press release here. Friday, [...]
Latest edition of the Catabasis Connection newsletter
La Force is happy to share the latest edition of the Catabasis Connection newsletter with updates on edasalonexent and information that Catabasis shared at the MDA Virtual Poster Session. Earlier [...]
